Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
42.73B | 43.13B | 41.53B | 39.63B | 37.25B | 29.61B | Gross Profit |
13.84B | 13.69B | 12.96B | 12.02B | 9.81B | 7.61B | EBIT |
9.41B | 9.28B | 8.76B | 7.78B | 5.76B | 3.94B | EBITDA |
11.15B | 10.80B | 11.70B | 8.85B | 6.69B | 4.88B | Net Income Common Stockholders |
7.78B | 6.83B | 7.50B | 7.25B | 5.49B | 3.43B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
46.11B | 49.04B | 51.06B | 45.88B | 43.66B | 40.49B | Total Assets |
94.75B | 95.19B | 89.51B | 79.19B | 76.21B | 68.65B | Total Debt |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Debt |
-29.11B | -32.04B | -29.99B | -25.88B | -43.65B | -36.56B | Total Liabilities |
14.08B | 13.82B | 14.18B | 12.72B | 12.82B | 10.31B | Stockholders Equity |
78.83B | 79.40B | 73.36B | 64.69B | 63.23B | 58.20B |
Cash Flow | Free Cash Flow | ||||
0.00 | 6.59B | 6.31B | 4.98B | 3.87B | 4.23B | Operating Cash Flow |
0.00 | 7.77B | 7.37B | 5.42B | 4.33B | 5.04B | Investing Cash Flow |
0.00 | -9.05B | -17.87B | 144.00M | -685.00M | -764.00M | Financing Cash Flow |
0.00 | -1.24B | -1.02B | -5.93B | -983.00M | -987.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥59.73B | 7.85 | 2.17% | 5.44% | 8.53% | ||
79 Outperform | ¥54.52B | 13.52 | 3.22% | 6.36% | 17.44% | ||
51 Neutral | $2.04B | -1.23 | -21.09% | 3.96% | 2.90% | -30.45% | |
€347.35M | 11.30 | 10.09% | 3.00% | ― | ― | ||
79 Outperform | ¥55.47B | 5.10 | 4.86% | 4.12% | 192.18% | ||
71 Outperform | ¥43.94B | 8.33 | 5.56% | 3.16% | ― | ||
66 Neutral | ¥60.89B | 9.65 | 4.54% | 3.21% | -1.94% |